Not Yet Recruiting
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
NCT06475755
- Conditions
- Anti Angiogenesis, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Tangdu Hospital of the Fourth Millitary Medical University Xi'an, Shaanxi, China